Development of New Office Furniture and Medical-Related Products
First written in FY2016. 18 of 21 entries say "Restated". Latest entry: FY2026-H1.
33 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「In this segment, we focused on developing and producing office furniture that creates new value for offices in response to changes in ways of working.」
Continued focusing on the development and production of office furniture addressing changes in ways of working. - FY2025-H1RestatedAnnual report
「In this segment, we focused on developing and producing office furniture that creates new value for offices in response to changes in ways of working.」
Continued focusing on the development and production of office furniture addressing changes in ways of working. - FY2024-Q2RestatedAnnual report
「In this segment, we focused on developing and producing office furniture that creates new value for offices in response to changes in ways of working.」
Continued focusing on the development and production of office furniture addressing changes in ways of working. - FY2024-Q1RestatedAnnual report
「In this segment, we focused on developing and producing office furniture that creates new value for offices in response to changes in ways of working, while advancing preparations to enter the in vitro diagnostic products market.」
Continued focusing on the development and production of office furniture addressing changes in ways of working. Preparations to enter the in vitro diagnostic products market are being developed separately as a new business initiative. - FY2023-Q3RestatedAnnual report
「In this segment, we focused on developing and producing office furniture that creates new value for offices in response to changes in ways of working, particularly private-room products for which demand is growing as opportunities for web conferencing increase.」
Continued focusing on the development and production of office furniture, particularly private-room products, addressing changes in ways of working. - FY2023-Q2RestatedAnnual report
「In this segment, we focused on developing and producing office furniture that creates new value for offices in response to changes in ways of working, particularly private-room products for which demand is growing as opportunities for web conferencing increase.」
Continued focusing on the development and production of office furniture addressing changes in ways of working, and on private-room products. - FY2022-Q3RestatedAnnual report
「Expansion of production capacity for private-room products, for which demand has increased due to the growth in web conferencing and other factors, and development of new products such as office chairs addressing new ways of using offices」
Continued expanding production capacity for private-room products and developing new products such as office chairs addressing new ways of using offices. - FY2022-Q2RestatedAnnual report
「Expansion of production capacity for private-room products, for which demand has increased due to the growth in web conferencing and other factors, and development of new products such as office chairs addressing new ways of using offices」
Continued expanding production capacity for private-room products and developing new products such as chairs addressing new ways of using offices. - FY2021AdvancedAnnual report
「We expanded production capacity for private-room products, for which demand has increased as opportunities for web conferencing have grown.」
For private-room products addressing new ways of working in the new normal, we advanced the expansion of production capacity in response to increased demand. - FY2021-Q3AdvancedAnnual report
「As opportunities for web conferencing increased, demand grew for private-room products that can create enclosed spaces with ventilation taken into account, and we expanded our production capacity for these products.」
For new private-room products addressing changes in the office environment, progress was made in expanding production capacity in response to increased demand. - FY2020RestatedAnnual report
「We also focused on developing new products for medical-related fields and launching them in the market.」
Continued developing new products for medical-related fields and conducting market launch activities. - FY2020-Q3RestatedAnnual report
「For products intended for medical-related fields, we conducted market launch activities for new products developed in the previous consolidated fiscal year.」
Continued market launch activities for new products for medical-related fields developed in the previous fiscal year. - FY2020-Q1RestatedAnnual report
「For products intended for medical-related fields, we conducted market launch activities for new products developed in the previous consolidated fiscal year.」
Continued market launch activities for new products for medical-related fields following development. - FY2019-Q3RestatedAnnual report
「We also developed new products for medical-related fields and conducted market launch activities.」
Continued developing new products for medical-related fields and conducting market launch activities. - FY2019-Q2RestatedAnnual report
「We also developed new products for medical-related fields and conducted market launch activities.」
Continued developing new products for medical-related fields and conducting market launch activities. - FY2019-Q1RestatedAnnual report
「We also continued expanding the sales organization for products intended for medical-related fields.」
Continued expanding the sales organization for products intended for medical-related fields. - FY2018-Q2RestatedAnnual report
「We also worked to expand the sales organization for products intended for medical-related fields.」
Continued expanding the sales organization for products intended for medical-related fields. - FY2018-Q1RestatedAnnual report
「Along with changing the factory layout and introducing robots to improve productivity, we worked to shorten product development lead times and improve quality by expanding product testing facilities and taking other measures.」
Continued shortening development lead times and improving quality by changing the factory layout, introducing robots and expanding product testing facilities. - FY2017-Q3RestatedAnnual report
「In this segment, we continued efforts to rationalize production using new equipment such as robots, as in the previous quarter, while also advancing activities for new product development and production ramp-up. We also worked to expand our sales organization for products intended for medical-related fields.」
Continued developing new products, ramping up production and expanding the sales organization for medical-related products. - FY2017-Q1RestatedAnnual report
「While focusing on the development of new core technologies and products for new sales fields」
Continued developing new core technologies and products for new sales fields. - FY2016First statedAnnual report
「Continue developing new products that could stimulate demand and expand sales through a fundamental review of product design, functionality, cost and other factors」
The policy is to continue developing new products, including office chairs in the high-volume segment and products for medical and clinical spaces.